Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer. | Cancers (Basel) | 2021 | 34944904 | PubTator, text mining | PubMed |
| The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective. | Cancers (Basel) | 2021 | 34944834 | PubTator, text mining | PubMed |
| Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability. | Front Cell Dev Biol | 2021 | 34901021 | PubTator, text mining | PubMed |
| NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review. | Curr Oncol | 2021 | 34898574 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer. | Cancers (Basel) | 2021 | 34885103 | PubTator, text mining | PubMed |
| Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer. | Adv Sci (Weinh) | 2021 | 34881526 | PubTator, text mining | PubMed |
| Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities. | Front Cell Dev Biol | 2021 | 34881245 | PubTator, text mining | PubMed |
| TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway. | Cell Death Dis | 2021 | 34876569 | PubTator, text mining | PubMed |
| Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma. | Biosci Rep | 2021 | 34859821 | PubTator, text mining | PubMed |
| Lipid raft-disrupting miltefosine preferentially induces the death of colorectal cancer stem-like cells. | Clin Transl Med | 2021 | 34841679 | PubTator, text mining | PubMed |
| Cell Cycle Regulation and DNA Damage Response Networks in Diffuse- and Intestinal-Type Gastric Cancer. | Cancers (Basel) | 2021 | 34830941 | PubTator, text mining | PubMed |
| Pilot Nanostring PanCancer pathway analysis of colon adenocarcinoma in a tertiary healthcare centre in Kerala, India. | Ecancermedicalscience | 2021 | 34824625 | PubTator, text mining | PubMed |
| STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer. | J Hematol Oncol | 2021 | 34809691 | PubTator, text mining | PubMed |
| Prognostic significance of HSF2BP in lung adenocarcinoma. | Ann Transl Med | 2021 | 34790765 | PubTator, text mining | PubMed |
| Identification of Cross-Pathway Connections via Protein-Protein Interactions Linked to Altered States of Metabolic Enzymes in Cervical Cancer. | Front Med (Lausanne) | 2021 | 34790674 | PubTator, text mining | PubMed |
| Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome. | Front Oncol | 2021 | 34790575 | PubTator, text mining | PubMed |
| Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer. | Dis Markers | 2021 | 34790279 | PubTator, text mining | PubMed |
| The construction and analysis of ceRNA network and patterns of immune infiltration in lung adenocarcinoma. | BMC Cancer | 2021 | 34781924 | PubTator, text mining | PubMed |
| Lactate induces aberration in the miR-30a-DBF4 axis to promote the development of gastric cancer and weakens the sensitivity to 5-Fu. | Cancer Cell Int | 2021 | 34758839 | PubTator, text mining | PubMed |
| Characterization of subcellular localization of eukaryotic clamp loader/unloader and its regulatory mechanism. | Sci Rep | 2021 | 34751190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=20